Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading. (16th September 2022)

• Record Type: Journal Article
• Authors: Jesinghaus, Moritz; Boxberg, Melanie; Schmitt, Maxime; Kriegsmann, Mark; Harms, Alexander; Lang, Corinna; Muley, Thomas; Winter, Hauke; Kriegsmann, Katharina; Warth, Arne; Stenzinger, Albrecht; Denkert, Carsten; Hoffmann, Hans; Safi, Seyer; Weichert, Wilko
• Is Part Of: Journal of pathology. Volume 8:Number 6(2022)
• Page Start: 567
• Page End: 578
• Publication Date: 2022-09-16
• Subjects: squamous cell carcinoma -- cellular dissociation grading -- lung -- biopsy -- tumour budding -- cell nest size; Pathology -- Periodicals; Diagnosis, Laboratory -- Periodicals; 616.07
• DOI: 10.1002/cjp2.295
• Languages: English
• ISSNs: 2056-4538

Abstract

Abstract: Grading of squamous cell carcinomas (SCCs) based on tumour budding and cell nest size has been termed cellular dissociation grading (CDG) and was suggested as a robust outcome predictor when assessed in biopsies and resections of various extrapulmonary SCCs. In pulmonary SCC (pSCC), this has so far been shown only for resected cancers. As most lung cancers are inoperable, it is of utmost importance to clarify whether the prognostic impact of CDG is retained in the biopsy setting. Two independent pSCC biopsy cohorts from Munich ( n = 134, non‐resected) and Heidelberg ( n = 135, resected) were assessed. Tumour budding and cell nest size measures were assembled into the three‐tiered CDG system (G1–G3). Data were correlated with clinicopathological parameters and overall‐ (OS), disease‐specific‐ (DSS), and disease‐free survival (DFS). Interobserver variability and concordance between biopsy and resection specimen were also investigated. CDG was highly congruent between biopsy and resection specimens ( κ = 0.77, p < 0.001). In both pSCC cohorts, biopsy‐derived CDG strongly impacted on OS, DSS, and DFS (e.g. DFS: p < 0.001). In multivariate survival analyses, CDG remained a stage independent predictor of survival in both cohorts (DFS: p < 0.001 respectively; hazard ratio Munich cohort: CDG‐G2: 4.31, CDG‐G3; 5.14; Heidelberg cohort: CDG‐G2: 5.87, CDG‐G3: 9.07). Interobserver agreement for CDG was almost perfect ( κ = 0.84, p < 0.001). We conclude that assessment of CDG based on tumour budding and cell nest size is feasible on pSCC biopsies and harbours stage independent prognostic information in resectable as well as non‐resectable pSCC. Integration of this grading approach into clinicopathological routine should be considered.